反応 #11674

ord-c28c8a5e0d064f24bb8eb2c35c7f7138

反応方程式

CCN(C(C)C)C(C)C
Diisopropylethylamine
COC(=O)CN1C(=O)[C@H](N)Cc2ccccc21.Cl
(R)-3-amino-1-carbomethoxymethyl-3,4-dihydrocarbostyril hydrochloride
O=C(O)c1cc2cc(Cl)ccc2[nH]1
5-chloroindole-2-carboxylic acid
On1nnc2cccnc21
1-hydroxy-7-azabenzotriazole
CCN=C=NCCCN(C)C.Cl
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride
COC(=O)CN1C(=O)[C@H](NC(=O)c2cc3cc(Cl)ccc3[nH]2)Cc2ccccc21
title compound
収率 26.3%
COC(=O)CN1C(=O)[C@H](NC(=O)c2cc3cc(Cl)ccc3[nH]2)Cc2ccccc21
(R)-1-carbomethoxymethyl-3-(5-chloroindole-2-carbonylamino)-3,4-dihydrocarbostyril
収率 26.3%

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他formed
  2. 2
    洗浄washed sequentially with 1.0 M aqueous hydrochloric acid (25 mL twice), 1.0 M aqueous sodium hydroxide (20 mL) and brine (20 mL)
  3. 3
    乾燥dried over anhydrous sodium sulfate
  4. 4
    その他evaporated under vacuum
  5. 5
    その他One half of the residue was purified by reverse phase preparative HPLC

実験手順

Alternatively, (R)-3-amino-1-carbomethoxymethyl-3,4-dihydrocarbostyril hydrochloride (19 mg) was added to a mixture of tetrahydrofuran (10 mL), 5-chloroindole-2-carboxylic acid (15 mg), 1-hydroxy-7-azabenzotriazole (12 mg), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (16 mg) at room temperature. Diisopropylethylamine (19 mg) was added, and the resulting yellow suspension was stirred under argon for 16 h, during which a solution formed. The solution was diluted with ethyl acetate (50 mL) and washed sequentially with 1.0 M aqueous hydrochloric acid (25 mL twice), 1.0 M aqueous sodium hydroxide (20 mL) and brine (20 mL), dried over anhydrous sodium sulfate and evaporated under vacuum. One half of the residue was purified by reverse phase preparative HPLC to provide the title compound (7.6 mg).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07098235B2uspto-grants-2006_08